Though this is only one case and a larger study size is needed, it seems to suggest that SALL4 expression could be used at least as an additional confirmation/refinement for the IPSS/WHO system to help predict the prognosis of MDS, and to confirm high-risk patients can get proper treatment as soon as possible. This evidence concerns the gene SALL4 and myelodysplastic syndrome.